During the past decade, PANAKEIA - Arzneimittelforschung Leipzig GmbH conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 12 clinical trials were completed, i.e. on average, 70.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PANAKEIA - Arzneimittelforschung Leipzig GmbH" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Affiris AG" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PANAKEIA - Arzneimittelforschung Leipzig GmbH" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Julius Clinical" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "PANAKEIA - Arzneimittelforschung Leipzig GmbH" are "Alzheimer's Disease" (9 trials), "Alzheimer Disease" (4 trials), "Migraine" (3 trials), "Multiple Sclerosis" (3 trials) and "Alzheimer´s Disease" (2 trials). Many other conditions were trialed in "PANAKEIA - Arzneimittelforschung Leipzig GmbH" in a lesser frequency.

Most popular intervention types in "PANAKEIA - Arzneimittelforschung Leipzig GmbH" are "Drug" (23 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Gantenerumab" (4 trials), "BI 409306" (2 trials), "Erenumab Dose 1" (2 trials) and "Erenumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "PANAKEIA - Arzneimittelforschung Leipzig GmbH" are 26 trials for "All" genders.

Currently, there are NaN active trials in "PANAKEIA - Arzneimittelforschung Leipzig GmbH". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in PANAKEIA - Arzneimittelforschung Leipzig GmbH, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in PANAKEIA - Arzneimittelforschung Leipzig GmbH, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".